Literature DB >> 18248388

Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes.

Hyemi Kim1, Eunjung Yang, Jeonggi Lee, Se-Hoon Kim, Jeon-Soo Shin, Joo Young Park, Sun Ju Choi, Se Jong Kim, In-Hong Choi.   

Abstract

Toll-like receptor 3 (TLR3) participates in the innate immune response by recognizing viral pathogens. In this study, human brain astrocytes were found to constitutively express TLR3, and this expression was increased by interferon-gamma (IFN-gamma) or double-stranded RNA (dsRNA). Treatment employing dsRNA in astrocytes induced IFN regulatory factor 3 (IRF3) phosphorylation, dimer formation and nuclear translocation followed by STAT1 activation. This treatment also activated nuclear factor-kappaB, p38 and c-Jun N-terminal kinase significantly, while activating extracellular signal-regulated kinase to a lesser extent. Treatment with anti-TLR3 antibody inhibited dsRNA-mediated interleukin-6 (IL-6) production. In the presence of mitogen-activated protein kinase inhibitors, astrocytes failed to secrete IL-6 in response to dsRNA treatment. Therefore, dsRNA-induced IL-6 production is dependent on mitogen-activated protein kinases and type I IFN production is dependent on IRF3 in brain astrocytes. These results suggest that brain inflammation, which produces inflammatory cytokines and type I IFNs, may enhance TLR3 expression in astrocytes. Additionally, upregulated TLR3 might modulate inflammatory processes by producing proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248388      PMCID: PMC2492940          DOI: 10.1111/j.1365-2567.2007.02799.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.

Authors:  Tammy Kielian; Nilufer Esen; Edward D Bearden
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

2.  Preferential expression and function of Toll-like receptor 3 in human astrocytes.

Authors:  Cinthia Farina; Markus Krumbholz; Thomas Giese; Gunther Hartmann; Francesca Aloisi; Edgar Meinl
Journal:  J Neuroimmunol       Date:  2004-11-11       Impact factor: 3.478

3.  Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes.

Authors:  Philip O Scumpia; Kindra M Kelly; Westley H Reeves; Bruce R Stevens
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

4.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Kenji Funami; Takashi Akazawa; Tsukasa Seya
Journal:  Nat Immunol       Date:  2003-01-21       Impact factor: 25.606

5.  RNA sequestration to pathological lesions of neurodegenerative diseases.

Authors:  S D Ginsberg; J E Galvin; T S Chiu; V M Lee; E Masliah; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

6.  Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine.

Authors:  J G Norris; E N Benveniste
Journal:  J Neuroimmunol       Date:  1993-06       Impact factor: 3.478

7.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

8.  Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.

Authors:  Minh Dang Nguyen; Thierry D'Aigle; Geneviève Gowing; Jean-Pierre Julien; Serge Rivest
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells.

Authors:  Matam Vijay Kumar; Chandrasekharam N Nagineni; Marian S Chin; John J Hooks; Barbara Detrick
Journal:  J Neuroimmunol       Date:  2004-08       Impact factor: 3.478

View more
  24 in total

Review 1.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

Review 2.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

Review 3.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

4.  Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis.

Authors:  Biju Bhargavan; Georgette D Kanmogne
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

5.  A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.

Authors:  Myrna R Rosenfeld; Marc C Chamberlain; Stuart A Grossman; David M Peereboom; Glenn J Lesser; Tracy T Batchelor; Serena Desideri; Andres M Salazar; Xiaobu Ye
Journal:  Neuro Oncol       Date:  2010-07-08       Impact factor: 12.300

6.  A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.

Authors:  Nicholas Butowski; Kathleen R Lamborn; Bee L Lee; Michael D Prados; Timothy Cloughesy; Lisa M DeAngelis; Lauren Abrey; Karen Fink; Frank Lieberman; Minesh Mehta; H Ian Robins; Larry Junck; Andres M Salazar; Susan M Chang
Journal:  J Neurooncol       Date:  2008-10-11       Impact factor: 4.130

7.  Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis.

Authors:  S Nair; S T Doh; J Y Chan; A-N Kong; L Cai
Journal:  Br J Cancer       Date:  2008-12-02       Impact factor: 7.640

Review 8.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

9.  Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation.

Authors:  Justin D Lathia; Eitan Okun; Sung-Chun Tang; Kathleen Griffioen; Aiwu Cheng; Mohamed R Mughal; Gloria Laryea; Pradeep K Selvaraj; Charles ffrench-Constant; Tim Magnus; Thiruma V Arumugam; Mark P Mattson
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

10.  Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia.

Authors:  Linnea Stridh; Amin Mottahedin; Maria E Johansson; Raul Chavez Valdez; Frances Northington; Xiaoyang Wang; Carina Mallard
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.